Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing

• Published in: Clinical Microbiology Reviews Vol. 19; no. 2; pp. 435 - 447
• Main Authors: PFALLER, M. A, DIEKEMA, D. J, SHEEHAN, D. J
• Format: Journal Article
• Language: English
• Published: Washington, DC American Society for Microbiology 01.04.2006
• Subjects: Antifungal Agents - administration & dosage; Antifungal Agents - pharmacology; Antifungal Agents - therapeutic use; Biological and medical sciences; Candida; Candida - drug effects; Candidiasis - drug therapy; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole - pharmacokinetics; Fluconazole - pharmacology; Fluconazole - therapeutic use; Fundamental and applied biological sciences. Psychology; Humans; Infectious diseases; Medical sciences; Microbial Sensitivity Tests - standards; Microbiology; Miscellaneous; Mycology; Reviews; Treatment Outcome; Breakpoint; Candidiasis; Yeast; Mycosis; Fluconazole; Drug susceptibility test; Review; Fungi; Infection; Antifungal agent; Candida; Fungi Imperfecti; Thallophyta
• ISSN: 0893-8512; 1098-6618
• DOI: 10.1128/CMR.19.2.435-447.2006

Classifications Services CMR Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CMR About CMR Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy CMR RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0893-8512 Online ISSN: 1098-6618 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to CMR .asm.org, visit: CMR